One-pot syntheses of alkenyl-phosphonio complexes of ruthenium(II), rhodium(III) and iridium(III) bearing p-cymene or pentamethylcyclopentadienyl groups

Reaction of [(p-cymene)RuCl₂(PPh₃)] (1) or [Cp^∗MCl₂(PPh₃)] (Cp^∗ = C₅Me₅) (3a: M = Rh; 4a: M = Ir) with 1-alkynes and PPh₃ were carried out in the presence of KPF₆, generating the corresponding alkenyl-phosphonio complexes, [(p-cymene)RuCl(PPh₃){CHCR(PPh₃)}](PF₆) (2a: R = Ph; 2b: R = p-tolyl) or [Cp^∗MCl(PPh₃){CHCPh(PPh₃)}](PF₆) (5: M = Rh; 6: M = Ir). Similar reactions of complexes [Cp^∗RhCl₂(L¹)] (3a: L¹ = PPh₃; 3c: L¹ = P(OMe)₃) with L² (L² = PPh₃, PMePh₂, P(OMe)₃) gave [Cp^∗RhCl(L¹)(L²)](PF₆) (7bb: L¹ = L² = PMePh₂; 7ca: L¹ = P(OMe)₃, L² = PPh₃; 7cc: L¹ = L² = P(OMe)₃). Alkenyl-phosphonio complex 5 was treated with P(OMe)₃ or 2,6-xylyl isocyanide, affording [Cp^∗RhCl(L){CHCPh(PPh₃)}](PF₆) (8a: L = P(OMe)₃; 8b: L = 2,6-xylNC). X-ray structural analyses of 2a, 6 and 8a revealed that the phosphonium moiety bonded to the C_β atom of the alkenyl group are E configuration.     

Synthesis and characterisation of a series of 1,2-phenylenedioxoborylcyclopentadienyl-metal complexes [Ti(IV), Zr(IV), Hf(IV), La(III), Ce(III), Yb(III), Sn(II) and Fe(II)]

The preparation of a series of 1,2-phenylenedioxoborylcyclopentadienyl-metal complexes is described. These are of formula [M{η⁵-C₅H₄(BX)}Cl₃] [M = Ti and X = CAT (2a), CAT^t (2b) or CAT^tt (2c); X = CAT^tt and M = Zr (4a) or Hf (4b)], [M{η⁵-C₅H₄(BX)}₂Cl₂] [M = Zr, X = CAT (3a) or CAT^t (3c); or M = Hf, X = CAT (3b) or CAT^t (3d)], [M{(μ-η⁵-C₅H₃BCAT)₂ SiMe₂}Cl₂] [M = Zr (5a) or Hf (5b)], [M{η⁵-C₅H₃(BCAT)₂}Cl₃] [M = Zr (6a) or Hf (6b)], [M{η⁵-C₅H₄BCAT}₃(THF)] [M = La (7a), Ce (7b) or Yb (7c)], [Sn{η⁵-C₅ H₄(BCAT^t)}Cl](8) and [Fe{η⁵-C₅H₄(BCAT^t)}₂] (9). The abbreviations refer to BO₂C₆H₄-1,2 (BCAT) and the 4-Bu^t (BCAT^t) and the (BCAT^tt) analogues. The compounds 2a-9 have been characterised by microanalysis, multinuclear NMR and mass spectra. The single crystal X-ray structure of the lanthanum compound 7a is presented.     

Synthesis, structures, and characterization of benzildiimine complexes of rhodium(III) and iridium(I)

The reactions of trans-[(PPh₃)₂M(CO)Cl] (M = Rh and Ir) with benzildiimine (H₂BDI = 2) derived from benzil-bis(trimethylsilyl)diimine (Si₂BDI) (1) in a 1:2 and 1:1 molar ratio afforded the cationic bis-benzildiiminato complexes [Rh(PPh₃)₂(HBDI)₂]Cl (3) and the mono-benzildiimine complex [Ir(PPh₃)₂(CO)(H₂BDI)]Cl (4), respectively. Both complexes are fully characterized using IR, FAB-MS, NMR spectroscopy and elemental analysis. The single crystal X-ray structure analysis reveals a distorted octahedral coordination geometry for the Rh(III) in 3 and a highly distorted square pyramidal geometry for Ir(I) in 4. In addition, the solid-state structure of Si₂BDI is reported here for the first time showing the substituents highly twisted because of steric reasons.     

Synthesis and characterisation of new N1-alkyl-3,5-dipyridylpyrazole derived ligands. Study of their reactivity with Pd(II) and Pt(II)

Two new pyrazole-derived ligands, 1-ethyl-3,5-bis(2-pyridyl)pyrazole (L¹) and 1-octyl-3,5-bis(2-pyridyl)pyrazole (L²), both containing alkyl groups at position 1 were prepared by reaction between 3,5-bis(2-pyridyl) pyrazole and the appropriate bromoalkane in toluene using sodium ethoxide as base.The reaction between L¹, L² and [MCl₂(CH₃CN)₂] (M = Pd(II), Pt(II)) resulted in the formation complexes of formula [MCl₂(L)] (M = Pd(II), L = L¹ (1); M = Pd(II), L = L² (2); M = Pt(II), L = L¹ (3); M = Pt(II), L = L² (4)). These complexes were characterised by elemental analyses, conductivity measurements, infrared, ¹H, ¹³C{¹H} NMR and HMQC spectroscopies. The X-ray structure of the complex [PtCl₂(L²)] (4) was determined. In this complex, Npyridine and Npyrazole donor atoms coordinate the ligand to the metal, which complete its coordination with two chloro ligands in a cis disposition.     

Half-sandwich ruthenium thiocarbonate complexes: Structures of CpRu(PPh3)2SCO2Bu, CpRu(dppe)SCO2Bu and CpRu(PPh3)(CO)SCO2Bu

Thiocarbonate ruthenium complexes of the form CpRu(L)(L′)SCO₂R (L = L′ = PPh₃ (1), 1/2 dppe (2), L = PPh₃, L′ = CO (3); R = Et (a), Buⁿ (b), C₆H₅ (c), 4-C₆H₄NO₂ (d)) have been synthesized by the reaction of the corresponding sulfhydryl complexes, CpRu(L)(L′)SH, with chloroformates, ROCOCl, at low temperature. The bis(triphenylphosphine) complexes 1 can be converted to 3 under CO atmosphere. The crystal structures of CpRu(PPh₃)₂SCO₂Buⁿ (1b), CpRu(dppe)SCO₂Buⁿ (2b), and CpRu(PPh₃)(CO)SCO₂Buⁿ (3b) are reported.     

Functional model for catecholase-like activity: Synthesis, structure, spectra, and catalytic activity of iron(III) complexes with substituted-salicylaldimine ligands

Four new mononuclear iron(III) complexes with the substituted-salicylaldimine ligands, [Fe(L¹)(TCC)] (1), [Fe(L²)(TBC)] (2), [Fe(L³)(TBC)] (3) and [Fe(L⁴)(TCC)](CH₃CN) (4) (HL¹ = N′-(5-OH-salicylaldimine)-diethylenetriamine, HL² = (N′-(5-Cl-salicylaldimine)-diethylenetriamine, HL³ N′-(5-Br-salicyl-aldimine)-dipropylenetriamine, HL⁴ = (N′-3,5-Br-salicylaldimine)-dipropylenetriamine, H₂TCC = tetrachlorocatechol, and H₂TBC = tetrabromocatechol), were prepared and characterized by XRD, EPR, and Mössbauer spectroscopy. The coordination sphere of the Fe(III) in complexes 1-4 is a distorted octahedral with N₃O₃ donors set which constructed by the Schiff-base ligands and the catecholate substrates of TBC or TCC. The in situ prepared Fe(III) complexes [Fe(L¹)Cl₂], [Fe(L²)Cl₂], [Fe(L³)(Cl₂)], and [Fe(L⁴)Cl₂] in absence of TBC or TCC show a high catecholase-like activity for the oxidation of 3,5-DTBC to the corresponding quinone 3,5-DTBQ.     

Reaction of [MCl2(CH3CN)2] (M = Pd(II), Pt(II)) compounds with N1-alkylpyridylpyrazole-derived ligands

Palladium(II) and platinum(II) complexes with N-alkylpyridylpyrazole-derived ligands, 2-(1-ethyl-5-phenyl-1H-pyrazol-3-yl)pyridine (L¹) and 2-(1-octyl-5-phenyl-1H-pyrazol-3-yl)pyridine (L²), cis-[MCl₂(L)] (M = Pd(II), Pt(II)), have been synthesised. Treatment of [PdCl₂(L)] (L = L¹, L²) with excess of ligand (L¹, L²), pyridine (py) or triphenylphosphine (PPh₃) in the presence of AgBF₄ and NaBPh₄ produced the following complexes: [Pd(L)₂](BPh₄)₂, [Pd(L)(py)₂](BPh₄)₂ and [Pd(L)(PPh₃)₂](BPh₄)₂. All complexes have been characterised by elemental analyses, conductivity, IR and NMR spectroscopies. The crystal structures of cis-[PdCl₂(L²)] (2) and cis-[PtCl₂(L¹)] (3) were determined by a single crystal X-ray diffraction method. In both complexes, the metal atom is coordinated by one pyrazole nitrogen, one pyridine nitrogen and two chlorine atoms in a distorted square-planar geometry. In complex 3, π-π stacking between pairs of molecules is observed.     

Cyclometalated rhodium(III) and iridium(III) complexes containing amino acids as N,O-chelates

The synthesis of bis-cyclometalated aminocarboxylato complexes [M(α-aminocarboxylato)(ptpy)₂] (M = Rh, 3, 4, 5; M = Ir, 6, 7, 8), ptpy = 2-(p-tolyl)pyridinato; aminocarboxylato = glycinato, l-alaninato, l-prolinato) from [{M(μ-Cl)(ptpy)₂}₂] (M = Rh, 1; M = Ir, 2) is described. The molecular structure of [Ir(l-alaninato)(ptpy)₂] (7) was confirmed by a single-crystal X-ray diffraction study. Compound 7 crystallized from methanol-iso-hexane in the space group P2₁. For 7 the two diastereoisomers Δ_Ir, S_C and Λ_Ir, S_C were found crystallizing twice per unit. Absorption and emission spectra were recorded. The rhodium compounds are weak yellow-green and the iridium species strong green emitters.     

Seven-coordinate Mn(II) and Co(II) complexes of the pentadentate ligand 2,6-diacetyl-4-carboxymethyl-pyridine bis(benzoylhydrazone): Synthesis, crystal structure and magnetic properties

The metal complexation properties of a functionalized N₃O₂ donor ligand H₂L², where H₂L² stands for 2,6-diacetyl-4-carboxymethyl-pyridine bis(benzoylhydrazone), are investigated by structural and spectroscopic (IR, ESI-MS and EPR) characterization of its Mn(II) and Co(II) complexes. The ligand H₂L² is observed to react essentially in the same fashion as its unmodified parent H₂L¹ producing mixed-ligand [M(H₂L²)(Cl₂)] complexes (M = Mn^II (1), Co^II (3)) upon treatment with MCl₂. Complexes [M(HL²)(H₂O)(EtOH)]BPh₄ (M = Mn 2, M = Co 4), incorporating the supporting ligand in the partially deprotonated form (HL²)⁻, are formed by salt elimination of the [M(H₂L²)(Cl₂)] compounds with NaBPh₄. Compounds 2 and 4 are isostructural featuring distorted pentagonal-bipyramidal coordinated Mn^II and Co^II ions, with the H₂O and EtOH ligands bound in axial positions. Intermolecular hydrogen bonding interactions of the type M-OH₂?O-M involving the H₂O ligands and the carbonyl functions of the supporting ligand assembles the complexes into dimers. Temperature-dependent magnetic susceptibility measurements (2-300 K) show a substantially paramagnetic Curie behavior for the Mn²⁺ compound (2) influenced by zero-field splitting and significant orbital angular momentum contribution for 4 (high-spin Co^II). The exchange coupling across the Mn^II-OH₂?O-Mn^II bridges in 2 was found to be less than 0.1 cm⁻¹, suggesting that no significant intradimer exchange coupling occurs via this path.     

Lanthanide(III) complexes with phosphoryl containing 1,8-naphthyridine: Crystal structures and vibrational spectra

The complexes of 2-[2-(diphenylphosphoryl)prop-2-yl]-1,8-naphthyridine (L) with lanthanide nitrates Ln(NO₃)₃ (Ln = Nd, Eu, Lu) were investigated to elucidate the coordination ability of a novel type of potentially tridentate ligands - phosphorylalkyl substituted naphthyridines. The X-ray crystal structures of [NdL₃]³⁺ · 3(NO₃)⁻ · MeCN (1), [EuL₃]³⁺ · 3(NO₃)⁻ · [Eu(NO₃)₃ · 4H₂O] · MeCN (2), and [LuL₃]³⁺ · 3(NO₃)⁻ · [Lu(NO₃)₃ · 3H₂O] · 2 MeCN · 0.5 H₂O (3) are reported together with their IR and Raman spectra. All the compounds studied contain isostructural [LnL₃]³⁺ cations and three NO₃⁻ counterions. Coordination of each L appears to be O,N,N tridentate-cyclic and coordination number of Ln is nine. Vibrational spectra of 1-3 are also compared with that of free ligand and model compounds.     

Secondary ligand-metal interactions in rhodium(III) and iridium(III) phosphoramidite complexes

The synthesis, characterization, and application in asymmetric catalytic cyclopropanation of Rh(III) and Ir(III) complexes containing (S_a,R_C,R_C)-O,O′-[1,1′-binaphthyl-2,2′-diyl]-N,N′-bis[1-phenyl-ethyl]phosphoramidite (1) are reported. The X-ray structures of the half-sandwich complexes [MCl₂(C₅Me₅)(1,κP)] (M = Rh, 2a; M = Ir, 2b) show that the metal-phosphoramidite bond is significantly shorter in the Ir(III) analog. Chloride abstraction from 2a (with CF₃SO₃SiMe₃ or with CF₃SO₃Me) and from 2b (with AgSbF₆) gives the cationic species [MCl(C₅Me₅)(1,2-η-1,κP)]⁺ (M = Rh, 3a; M = Ir, 3b), which display a secondary interaction between the metal and a dangling phenethyl group (NCH(CH₃)Ph) of the phosphoramidite ligand, as indicated by NMR spectroscopic studies. Complexes 3a and 3b slowly decompose in solution. In the case of 3b, the binuclear species [Ir₂Cl₃(C₅Me₅)₂]⁺ is slowly formed, as indicated by an X-ray study. Preliminary catalytic tests showed that 3a cyclopropanates styrene with moderate yield (35%) and diastereoselectivity (70:30 trans:cis ratio) and with 32% ee (for the trans isomer).     

Pd(II) complexes containing N-alkyl-3-pyridine-5-trifluoromethyl pyrazole ligands: Synthesis, NMR studies and X-ray crystal structures

Palladium [PdCl₂(L)] complexes with N-alkylpyridylpyrazole derived ligands [2-(5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L¹), 2-(1-ethyl-5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L²), 2-(1-octyl-5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L³), and 2-(3-pyridin-2-yl-5-trifluoromethyl-pyrazol-1-yl)ethanol (L⁴) were synthesised. The crystal and molecular structures of [PdCl₂(L)] (L = L², L³, L⁴) were resolved by X-ray diffraction, and consist of monomeric cis-[PdCl₂(L)] molecules. The palladium centre has a typical square-planar geometry, with a slight tetrahedral distortion. The tetra-coordinate metal atom is bonded to one pyridinic nitrogen, one pyrazolic nitrogen and two chlorine ligands in cis disposition. Reaction of L (L², L⁴) with [Pd(CH₃CN)₄](BF₄)₂, in the ratio 1M:2L, gave complexes [Pd(L)]₂(BF₄)₂. Treatment of [PdCl₂(L)] (L = L², L⁴) with NaBF₄ and pyridine (py) and treatment of the same complexes with AgBF₄ and triphenylphosphine (PPh₃) yielded [Pd(L)(py)₂](BF₄)₂ and [Pd(L)(PPh₃)₂](BF₄)₂ complexes, respectively. Finally, reaction of [PdCl₂(L⁴)] with 1 equiv of AgBF₄ yields [PdCl(L⁴)](BF₄).     

Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production

Gold compounds are being investigated as potential antitumor drugs. Some gold(III) derivatives have been shown to induce cell death in solid tumors but their mechanism of action differs from that of cisplatin, since most of these compounds do not bind to DNA. We have explored cellular events triggered by three different iminophosphorane-organogold(III) compounds in leukemia cells (a neutral compound with two chloride ligands [Au{κ²-C,N-C₆H₄(PPh₂ = N(C₆H₅)-2}Cl₂] 1, and two cationic compounds with either a dithiocarbamate ligand [Au{κ²-C,N-C₆H₄(PPh₂ = N(C₆H₅)-2}(S₂CN-Me₂)]PF₆2, or a water-soluble phosphine and a chloride ligand [Au{κ²-C,N-C₆H₄(PPh₂ = N(C₆H₅)-2}(P{Cp(m-C₆H₄-SO₃Na)₂}₃) Cl]PF₆3). All three compounds showed higher toxicity against leukemia cells when compared to normal T-lymphocytes. Compounds 1 and 2 induced both necrosis and apoptosis, while 3 was mainly apoptotic. Necrotic cell death induced by 1 and 2 was Bax/Bak- and caspase-independent, while apoptosis induced by 3 was Bax/Bak-dependent. Reactive oxygen species (ROS) production at the mitochondrial level was a critical step in the antitumor effect of these compounds.     

Preparation, characterization, and catalytic properties of (triphenylphosphine)ruthenium complexes bearing N,O,N′-tridentate ligands

Preparation and characterization of (triphenylphosphine)ruthenium complexes bearing N,O,N′-tridentate ligands, [(L₁)RuCl(PPh₃)₂](BF₄) (L₁ = 2-[(2-pyridylmethoxy)methyl]pyridine), 1), [(L₂)RuCl(PPh₃)₂](BF₄) (L₂ = 8-(2-pyridylmethoxy)quinoline, 2) and [(L₃)RuCl₂(PPh₃)] (L₃ = 2-[(2-pyridylmethoxy)methyl]quinoline, 3) are described. Complexes 1-3 have been characterized by NMR and elemental analyses. Molecular structures of 2 and 3 have been determined by X-ray crystallography. Both compounds exhibit the octahedral geometry. L₂ adopts the facial configuration in 2 while L₃ is in a mer-arrangement in 3. Complexes 1-3 have proven to be able to catalyze the transfer hydrogenation of several ketones to alcohols in the presence of KOH and 2-propanol at refluxing, among which complex 3 was found to be the most active.     

Copper(II) complexes with monocarboxylate ligands bearing different substituent groups: Synthesis and spectroscopic studies

In our continuing efforts to explore the effects of substituent groups of ligands in the formation of supramolecular coordination structures, seven new Cu^II complexes formulated as [Cu₂(L¹)₄(DMF)₂] (1), {[Cu₂(L¹)₄(Hmta)](H₂O)_0.75}_∞ (2), [Cu₂(L²)₄(2,2′-bipy)₂] (3), [Cu₂(L³)₄(H₂O)₂] (4), [Cu₂(L³)₄(Hmta)]_∞ (5), [Cu₂(L³)₄(Dabco)]_∞ (6) and [Cu₂(L³)₄(Pz)]_∞ (7) with three monocarboxylate ligands bearing different substituent groups HL¹-HL³ (HL¹ = phenanthrene-9-carboxylic acid, HL² = 2-phenylquinoline-4-carboxylic acid, HL³ = adamantane-1-carboxylic acid, Hmta = hexamethylenetetramine, 2,2′-bipy = 2,2′-bipyridine, Dabco = 1,4-diazabicyclo[2.2.2] octane and Pz = pyrazine), have been prepared and characterized by X-ray diffraction. In 1, 2 and 4-7, each Cu^II ion is octahedrally coordinated, and carboxylate acid acts as a syn-syn bridging bidentate ligand. While each Cu^II ion in 3 is penta-coordinated in a distorted square-pyramidal geometry. 1 and 4 both show a dinuclear paddle-wheel block, while 2, 5, 6 and 7 all exhibit an alternated 1D chain structure between dinuclear paddle-wheel units of the tetracarboxylate type Cu₂-(RCO₂)₄ and the bridging auxiliary ligands Hmta, Dabco and Pz. Furthermore, 3 has a carboxylic unidentate and μ_1,1-oxo bridging dinuclear structure with the chelating auxiliary ligand 2,2′-bipy. Moreover, complexes 1-6 were characterized by electron paramagnetic resonance (EPR) spectroscopy.     

Influence of the phosphine arrangement on the reactivity of palladium(II) and platinum(II) polyphosphine complexes with copper(I) chloride

The distorted square-planar complexes [Pd(PNHP)Cl]Cl (1) (PNHP = bis[2-(diphenylphosphino)ethyl]amine), [M(P₃)Cl]Cl [P₃ = bis[2-(diphenylphosphino)ethyl]phenylphosphine; M = Pd (2), Pt (3)] and [Pt(NP₃)Cl]Cl (5) (NP₃ = tris[2-(diphenylphosphino)ethyl]amine), coexisting in the later case with a square-pyramidal arrangement, react with one equivalent of CuCl to give the mononuclear heteroionic systems [M(L)Cl](CuCl₂) [L = PNHP, M = Pd (1a); L = P₃, M = Pd (2a), Pt (3a); L = NP₃, M = Pt (5a)]. The crystal structure of 3a confirms that Pt(II) retains the distorted square-planar geometry of 3 in the cation with P₃ acting as tridentate chelating ligand, the central P atom being trans to one chloride. The counter anion is a nearly linear dichlorocuprate(I) ion. However, the five-coordinate complexes [Pd(NP₃)Cl]Cl (4), [M(PP₃)Cl]Cl (M = Pd (6), Pt (7); PP₃ = tris[2-(diphenylphosphino)ethyl] phosphine) containing three fused five-membered chelate rings undergo a ring-opening by interaction with one (4, 6, 7) and two (6, 7) equivalents of CuCl with formation of neutral MCu(L)Cl₃ [L = NP₃, M = Pd (4a); L = PP₃, M = Pd (6a), Pt (7a)] and ionic [MCu(PP₃)Cl₂](CuCl₂) [M = Pd (6b), Pt (7b)] compounds, respectively. The heteronuclear systems were shown by ³¹P NMR to have structures where the phosphines are acting as tridentate chelating ligands to M(II) and monodentate bridging to Cu(I). Further additions of CuCl to the neutral species 6a and 7a in a 1:1 ratio resulted in the achievement of the ionic complexes 6b and 7b with ions as counter anions. It was demonstrated that the formation of heterobimetallic or just mononuclear mixed salt complexes was clearly influenced by the polyphosphine arrangement with the tripodal ligands giving the former compounds. However, complexes [M(NP₃)Cl]Cl constitute one exception and the type of reaction undergone versus CuCl is a function of the d⁸ metal centre.     

Synthesis, crystal structures and characterization of three novel complexes with N-[2-(2-hydroxybenzylideneamino)ethyl]-4-methyl-benzene-sulfonamide as ligand

Reaction of the N-tosyl-ethylenediamine and salicylaldehyde forms a new sulfonamide Schiff base N-[2-(2-hydroxybenzylideneamino)ethyl]-4-methyl-benzene-sulfonamide (H₂L). Three novel complexes constructed from H₂L, namely, [M(HL)₂] · xH₂O (M = Cu, x = 0 for 1, M = Ni, x = 0 for 2 and M = Zn, x = 1 for 3) have been prepared and characterized via X-ray single-crystal diffraction, elemental analysis, X-ray powder diffraction (XRPD), FT-IR, UV-Vis, TGA and photoluminescence measurements. Complex hydrogen bonds, C-H···π and π-π stacking interactions lead 1-3 to present 1-D, 2-D and 3-D supramolecular architectures, respectively.     

Biotechnological application of homo- and heterotrinuclear iron(III) furoates for cultivation of iron-enriched Spirulina

New trinuclear iron(III) furoates with the general formula [Fe₃O(α-fur)₆(R-OH)₃]X, where α-fur C₄H₃OCOO, R = CH₃ (1), C₂H₅ (2), n-C₃H₇ (3), n-C₄H₉ (4), X = NO₃⁻ (1-4); [Fe₃O(α-Fur)₆(DMF)(CH₃OH)₂]NO₃ (5); [Fe₃O(α-Fur)₆(H₂O)(CH₃OH)₂]Cl (6); [Fe₂MO(α-Fur)₆(L)(H₂O)₂], where L = THF (7-9), DMF (10-12), M = Mn²⁺ (7, 10), Co²⁺ (8, 11), Ni²⁺ (9, 12) and [Fe₂MO(α-Fur)₆(3Cl-Py)₃], where M = Mn²⁺ (13), Co²⁺ (14), Ni²⁺ (15); have been prepared and investigated by Mössbauer and IR spectroscopy. The X-ray crystal structure for the 1·2CH₃OH complex indicates that it crystallizes in the monoclinic crystal system (P2₁/n) and has a structure typical of μ₃-O-bridged trinuclear iron(III) compounds. Coordination compounds 1, 4, 7, 8 can be used as regulators of the biochemical composition of cyanobacterium Spirulina platensis biomass. The supplementation of these compounds, in concentrations exceeding 5-10 mg/l, increases the content of iron, amino acids, peptides and carbohydrates in Spirulina.     

Syntheses and characterization of triorganotin(IV) complexes of Schiff base derive from 4-amino-5-phenyl-4H-1,2,4-triazole-3-thiol and 5-amino-1,3,4-thiadiazole-2-thiol with p-phthalaldehyde

Eight triorganotin complexes of the types [(R₃Sn)₂(C₂₄H₁₆N₈S₂)].Y (R = Ph, Y = 0 (1); R = PhCH_2, Y = 2CH₃OH (2); R = n-Bu, Y = 0 (3)), [(R₃Sn)₂(C₂₄H₁₆N₈S₂)]_n (R = Me (4)), [(R₃Sn)₂(C₁₂H₆N₆S₄)] · Y (R = Ph, Y = CH₂Cl₂ (5); R = PhCH_2, Y = 0 (6)) and [(R₃Sn)₂(C₁₂H₆N₆S₄)] (R = Bu (7), R = Me (8)) have been obtained by H₂L₁ (H₂L₁ derived from 4-amino-5-phenyl-4H-1,2,4-triazole-3-thiol) and H₂L₂ (H₂L₂ derived from 5-amino-1,3,4-thiadiazole-2-thiol) with triorganotin chloride in the presence of sodium ethoxide. All the complexes were characterized by elemental, IR and NMR spectra analyses, except for complexes 1, 3, 6 and 8, other complexes were also characterized by X-ray diffraction analyses, which reveal that complexes 2 and 5 are dinuclear structures, complex 4 has a 2D network structure and complex 7 forms a macrocyclic structure linked by intermolecular N → Sn interactions.     

Synthesis, characterization and cytotoxic properties of platinum(II) complexes containing the nucleosides adenosine and cytidine

Cytidine (cyt) and adenosine (ado) react with cis-[L₂Pt(μ-OH)]₂(NO₃)₂ (L = PMe₃, PPh₃) in various solvents to give the nucleoside complexes cis-[L₂Pt{cyt(− H),N³N⁴}]₃(NO₃)₃ (L = PMe₃, 1),cis-[L₂Pt{cyt(− H),N⁴}(cyt,N³)]NO₃ (L = PPh₃, 2), cis-[L₂Pt{ado(− H),N¹N⁶}]₂(NO₃)₂ (L = PMe₃, 3) and cis-[L₂Pt{ado(− H),N⁶N⁷}]NO₃ (L = PPh₃, 4). When the condensation reaction is carried out in solution of nitriles (RCN, R = Me, Ph) the amidine derivatives cis-[(PPh₃)₂PtNH=C(R){cyt(− 2H)}]NO₃ (R = Me, 5a; R = Ph, 5b) and cis-[(PPh₃)₂PtNH=C(R){ado(− 2H)}]NO₃ (R = Me, 6a: R = Ph, 6b) are quantitatively formed. The coordination mode of these nucleosides, characterized in solution by multinuclear NMR spectroscopy and mass spectrometry, is similar to that previously observed for the nucleobases 1-methylcytosine (1-MeCy) and 9-methyladenine (9-MeAd). The cytotoxic properties of the new complexes, and those of the nucleobase analogs, cis-[(PPh₃)₂PtNH=C(R){1-MeCy(− 2H)}]NO₃ (R = Me, 7a: R = Ph, 7b), cis-[(PPh₃)₂PtNH=C(R){9-MeAd(− 2H)}]NO₃ (R = Me, 8a: R = Ph, 8b) have been investigated in a wide panel of human cancer cells. Interestingly, whereas the Pt(II) nucleoside complexes (1-4) did not show appreciable cytotoxicity, the corresponding amidine derivatives (7a, 7b, 8a, 8b, 5b, and 6b) exhibited a significant in vitro antitumor activity.